HP Pyruvate MRI in Cancers

Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Jan 20, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to see and understand tumors in cancer patients using a special type of MRI that looks at how cancer cells use sugar. Normally, cancer cells consume more sugar than healthy cells, which can affect how they produce energy. The researchers are testing a method called hyperpolarized 13C MRI, which uses a special form of carbon linked to sugar (pyruvate) to help visualize this process in real time. This could help doctors better detect and characterize different types of cancers, as this imaging technique has not been widely tested before.

To participate in this trial, you need to have a clinical diagnosis of a tumor and a scheduled MRI appointment. It’s important that you can safely undergo an MRI. Unfortunately, if you don’t have a tumor diagnosis, you won’t be eligible for this study. If you decide to join, you’ll experience a standard MRI procedure with the added benefit of this new imaging technique, which could provide valuable information for cancer research. This trial is currently recruiting participants of all genders, aged between 65 and 74, and 32 to 141 years old, so there may be a chance for you or someone you know to get involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical tumor diagnosis
• • Patients with pre-existing MR imaging appointments
• • Must be able to undergo MR
• Exclusion Criteria:
• • No tumor diagnosis